The European Commission’s attempt to hold AstraZeneca (AZ) responsible for the delayed and truncated supply of its Covid-19 vaccine appears to have not produced the...
AGC Biologics has agreed to supply plasmid DNA (pDNA) to Pfizer/BioNTech for their RNA-based Covid-19 vaccine. The biopharma CDMO based in Heidelberg, Germany, will...
UK-based pharmatech Exscientia has entered into a binding agreement to buy Vienna-based Allcyte, a specialist in precision medicine using artificial intelligence (AI)...
Just weeks after spending $60 million buying UK electro-chemical producer H.K. Wentworth, Element Solutions has offered to acquire Coventya, a French international...
In a stunning setback to the company’s ambitions of launching its mRNA-based Covid-19 vaccine in the third quarter, results from CureVac’s Phase 2b/3 trial showed the...
An initial public offering for Wintershall Dea, the oil and gas producer owned by BASF and Letter One – last planned for the second half of 2021 – will not take place...
Evonik has entered into an agreement to buy Infinitec Activos, a privately owned Spanish company that specializes in the development and production of novel delivery...
Flagship Pioneering, the venture capital fund behind US Covid vaccine manufacturer Moderna and other biotechs, said it has raised an additional $2.23 billion for its fund...
Dutch specialty chemicals company Nouryon has signed a 10-year agreement with Finland’s Metsä Fibre, a major producer of bioproducts, biochemicals and bioenergy, to...
Dow is planning to build an integrated methylene diphenyl diisocyanate (MDI) distillation and prepolymers plant at its site in Freeport, Texas, USA, to support rising...
